These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany. Wirth D, Dass R, Hettle R. BMC Health Serv Res; 2017 Mar 08; 17(1):182. PubMed ID: 28270207 [Abstract] [Full Text] [Related]